Daniel Schneider

Daniel Schneider has a diverse work experience spanning over two decades. Daniel is currently working as the Head of Commercial at N-Power Medicine, Inc. since August 2021. Prior to that, they worked at Genentech as the Diagnostic Strategy Leader in the Global Product Strategy (GPS) department from June 2018 to August 2021. Before joining Genentech, they served as the Director of Diagnostics and Personalized Medicine at Teva Pharmaceuticals from July 2016 to March 2018. Daniel also held various positions at Genomic Health, including Senior Director of International Sales & Marketing for the Oncotype DX Assay from August 2013 to June 2016, Director of International Marketing from May 2010 to July 2013, and Associate Director of Channel Marketing from April 2006 to May 2010. Daniel started their career as a Marketing Intern at Eli Lilly and Company in June 2001. Daniel has also worked at Helix Medical Communications as a Client Services Director from October 2002 to March 2006 and at the American Academy of Ophthalmology as a Subspecialty Manager from April 1997 to June 2000.

Daniel Schneider obtained their Bachelor's degree in American Studies from The George Washington University. The specific years of their education are not provided. Subsequently, they pursued an MBA/MBI degree in Business Informatics, with a focus on International Marketing, from the Rotterdam School of Management, Erasmus University. Daniel attended this program from 2000 to 2002.